-+ 0.00%
-+ 0.00%
-+ 0.00%

SIONNA THERAPEUTICS, - TO INITIATE SION-451 + SION-2222 PHASE 2A TRIAL IN Q1 2027

Reuters·09/14/2026 20:01:00

Please log in to view news